Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
NRXP
NRXP
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
NRXP News
NRx Pharmaceuticals Receives FDA Clearance for Depression Clinical Trial
3d ago
Newsfilter
Highlights from New to The Street Broadcast
Apr 25 2026
Yahoo Finance
NRx Receives Positive FDA Review Letter for Ketamine ANDA
Apr 22 2026
Newsfilter
NRx Receives Preliminary Label Alignment from FDA for Ketamine Product
Apr 06 2026
Newsfilter
NRx Pharmaceuticals Receives FDA Preliminary Label Alignment
Apr 06 2026
Yahoo Finance
Analysis of NRx Pharmaceuticals' Cash Burn and Market Outlook
Mar 29 2026
Yahoo Finance
NRx Pharmaceuticals Releases FY 2025 Financial Results
Mar 24 2026
seekingalpha
NRx Pharmaceuticals to Announce Q4 Earnings on March 24
Mar 23 2026
seekingalpha
NRx Pharmaceuticals Receives Positive FDA Feedback
Mar 17 2026
NASDAQ.COM
NRx Receives FDA Confirmatory Meeting Minutes for NRX-100 Approval Path
Mar 17 2026
Newsfilter
NRx and FDA Meeting Advances New Drug Application for NRX-100
Feb 17 2026
Newsfilter
NRx Pharmaceuticals Sets Date for 2025 Annual Meeting and Proposal Deadline
Jan 16 2026
Globenewswire
NRx Pharmaceuticals Licenses RWE from 70,000 Patients to Support NRX-100 FDA Approval
Jan 14 2026
stocktwits
NRX Pharmaceuticals' NRX-100 Receives FDA Fast Track Designation Supported by 70,000 Patient Real-World Evidence
Jan 14 2026
Globenewswire
BTIG Raises Hudson Pacific Price Target to $26
Jan 02 2026
Benzinga
NRx Pharmaceuticals Repays $5.4 Million Debt, Positions for Accelerated Growth in 2026
Dec 18 2025
Globenewswire
Show More News
